Beskrivelse
pharmacotherapies for depression", EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol.16, no.6, 1 August 2006 (2006-08-01) , pages 391-402, XP025110892, ELSEVIER SCIENCE
PUBLISHERS BV, AMSTERDAM, NL ISSN: 0924-977X, DOI:
10.1016/J.EURONEURO.2005.12.002 [retrieved on 2006-08-01], HILLERT A ET AL:
"Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome--a functional approach.", PHARMACOPSYCHIATRY, vol.25, no.5, September 1992 (1992-09), pages 213-217, XP009156770, ISSN: 0176-3679
Enclosed is a translation of the patent claims in Norwegian. Please note that as per the Norwegian Patents Acts, section 66i the patent will receive protection in Norway only as far as there is agreement between the translation and the language of the application/patent granted at the EPO. In matters concerning the validity of the patent, language of the application/patent granted at the EPO will be used as the basis for the decision. The patent documents published by the EPO are available through Espacenet (http://worldwide.espacenet.com) or via the search engine on our website here: https://search.patentstyret.no/
Krav
IPC-klasse
Fullmektig i Norge:
Org.nummer: 982702887
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2007.08.03, US 953694 P
GYERTYAN I ET AL: "P.3.d.006 Pharmacological profile of RGH-188, a novel dopamine D3/D2 receptor antagonist/partial agonist atypical antipsychotic", EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 16, 1 January 2006 (2006-01-01), page S432, XP027969902, ELSEVIER SCIENCE PUBLISHERS BV, AMSTERDAM, NL ISSN: 0924-977X [retrieved on 2006-01-01] (B1)
HILLERT A ET AL: "Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome--a functional approach.", PHARMACOPSYCHIATRY, vol. 25, no. 5, September 1992 (1992-09), pages 213-217, XP009156770, ISSN: 0176-3679 (B1)
JANICAK PHILIP G ET AL: "Risperidone monotherapy versus risperidone or haloperidol plus sertraline for major depression with psychosis: Results of a pilot, double-blind, placebo-controlled trial", BIOLOGICAL PSYCHIATRY, vol. 59, no. 8, Suppl, 1 April 2006 (2006-04-01), page 146S, XP009156754, ELSEVIER SCIENCE, NEW YORK, NY, US ISSN: 0006-3223 (B1)
MATHEWS J ET AL: "Antidepressant efficacy of olanzapine as monotherapy in major depressive disorder, without psychosis: A pilot study", PSYCHIATRY RESEARCH: NEUROIMAGING, vol. 146, no. 2, 31 March 2006 (2006-03-31), pages 149-155, XP027998411, ELSEVIER, AMSTERDAM, NL ISSN: 0925-4927, DOI: 10.1016/J.PSCYCHRESNS.2005.08.003 [retrieved on 2006-03-31] (B1)
NUMBERG.: 'Managing Treatment-Emergent Sexual Dysfunction Associated with Serotogenic Antidepressants: Before and After Sildenafil' JOURNAL OF PSYCHIATRIC PRACTICE vol. 7, 2001, page 98, XP008130700 (B1)
WO-A2-2008/139235 (B1)
Thomson Reuters Drug News (formerly DailyDrugNews.com): "Gedeon Richter signs new agreement for antipsychotic RGH-188", Thomson Reuters Integrity , 16 May 2006 (2006-05-16), XP002670062, Retrieved from the Internet: URL:https://integrity.thomson-pharma.com/i ntegrity/xmlxsl/pk_ref_list.xml_show_ficha _ref?p_ref_id=990898 [retrieved on 2012-02-22] (B1)
US-A1- 2006 229 297 (B1)
US-A1- 2007 042 014 (B1)
US-B2- 7 030 122 (B1)
WO-A1-2006/082456 (B1)
PAPAKOSTAS ET AL: "Dopaminergic-based pharmacotherapies for depression", EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 16, no. 6, 1 August 2006 (2006-08-01) , pages 391-402, XP025110892, ELSEVIER SCIENCE PUBLISHERS BV, AMSTERDAM, NL ISSN: 0924-977X, DOI: 10.1016/J.EURONEURO.2005.12.002 [retrieved on 2006-08-01] (B1)
Statushistorie
| Hovedstatus | Beslutningsdato, detaljstatus |
|---|---|
| EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
| EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
|
Dato
Type korrespondanse
Journal beskrivelse
|
|---|
|
Innkommende
EP Publiseringsdokument fra EPO
|
|
Innkommende
EP Publiseringsdokument fra EPO
|
|
Utgående
EP Batch Varsel om betaling av første årsavgift (3319)
|
|
Utgående
EP Registreringsbrev (3210)
|
|
Innkommende
Søknadsskjema Patent
|
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
| Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
|---|---|---|---|---|
| Årsavgift 17. avg. år (EP) | 2024.08.29 | 7150 | 1/DENNEMEYER CO S.A R.L. | Betalt og godkjent |
| Årsavgift 16. avg. år (EP) | 2023.08.24 | 5200 | 1/DENNEMEYER CO S.A R.L. | Betalt og godkjent |
| Årsavgift 15. avg. år (EP) | 2022.08.24 | 4850 | 1/DENNEMEYER CO S.A R.L. | Betalt og godkjent |
| Årsavgift 14. avg. år (EP) | 2021.08.23 | 4500 | 1/DENNEMEYER CO S.A R.L. | Betalt og godkjent |
| Årsavgift 13. avg. år (EP) | 2020.08.21 | 4200 | 1/DENNEMEYER CO S.A R.L. | Betalt og godkjent |
| Årsavgift 12. avg. år (EP) | 2019.08.27 | 3850 | 1/DENNEMEYER CO S.A R.L. | Betalt og godkjent |
| Årsavgift 11. avg. år (EP) | 2018.08.27 | 3500 | 1/DENNEMEYER CO S.A R.L. | Betalt og godkjent |
| 31721511 expand_more expand_less | 2018.01.04 | 5500 | Zacco Norway AS | Betalt |
|
Valideringsgebyr EP-patent
5500 = 1 X 5500
|